Pfizer said its candidate to vaccinate against a potentially fatal infection that harms patients' bowels has received fast-track designation from the U.S. Food and Drug Administration.
from WSJ.com: US Business http://ift.tt/1qEtXDA
via IFTTT
from WSJ.com: US Business http://ift.tt/1qEtXDA
via IFTTT
No comments:
Post a Comment